Urology Research & Practice
Original Article

Does morbid obesity influence the success and complication rates of extracorporeal shockwave lithotripsy for upper ureteral stones?

1.

Department of Urology, Dicle University Faculty of Medicine, Diyarbakır, Turkey

2.

Department of Urology, Ministry of Health Numune Training and Research Hospital, Ankara, Turkey

3.

Department of Urology Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey

4.

Department of Clinical Microbiology and Infectious Diseases, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey

5.

Department of Urology, Ahi Evran University Faculty of Medicine, Kırşehir, Turkey

Urol Res Pract 2015; 41: 20-23
DOI: 10.5152/tud.2015.94824
Read: 1465 Downloads: 914 Published: 25 July 2019

Abstract

Objective: The aim of the current study was to investigate whether obesity influences the outcome of extracorporeal shockwave lithotripsy (ESWL) treatment for upper ureteral stones.

 

Material and methods: This is a retrospective study of 134 patients who underwent ESWL between June 2011 and May 2014. Patients were divided into 2 groups. Group 1 comprised 94 patients of normal weight, and group 2 comprised 40 morbidly obese patients. Patients in both groups had upper ureteral stones.

 

Results: The mean age of groups 1 and 2 was 45.6±12.1 and 45.3±15.5 years, respectively (p=0.98). There was no significant difference in demographic variables between the groups. The mean stone size in Groups 1 and 2 was 81.7±25.7 mm² and 86.3±22.4 mm², respectively (p=0.51), the mean body mass index (BMI) was 27.4±2.9 and 42.9±2.1, respectively (p<0.01), the mean number of ESWL sessions was 2.4±0.6 and 2.4±0.7, respectively (p=0.97), and the mean follow-up time was 7.1±3.4 and 6.6±2.8 weeks, respectively (p=0.67). The overall stone-free rate was 82% in group 1 and 67% in group 2 (p=0.01).

 

 

Conclusion: It is well-known that morbidly obese patients have higher rates of anesthesia-related problems due to the comorbidities commonly observed in this population. In the current study, we found that ESWL is a safe and acceptable treatment option for morbidly obese patients with upper ureteral stones.

Files
EISSN 2980-1478